Open AccessNivolumab Plus Cabozantinib Improves Outcomes Compared With Sunitinib for Advanced Renal Cell Carcinoma
Author(s) -
Isaac
Publication year - 2021
Publication title -
journal of clinical outcomes management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 19
eISSN - 1938-1336
pISSN - 1079-6533
DOI - 10.12788/jcom.0058
Subject(s) - cabozantinib , sunitinib , renal cell carcinoma , nivolumab , medicine , oncology , tyrosine kinase inhibitor , urology , immunotherapy , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom